1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

  • US 8,722,684 B2
  • Filed: 06/15/2007
  • Issued: 05/13/2014
  • Est. Priority Date: 06/16/2006
  • Status: Active Grant
First Claim
Patent Images

1. Compound 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or a pharmaceutically acceptable salt thereof in a crystalline form characterized by an XRPD pattern as shown in any of FIGS. 1-17.

View all claims

    Thank you for your feedback